Cite
Recombinant human megakaryocyte growth and development factor increases levels of circulating haemopoietic progenitor cells post chemotherapy in patients with acute myeloid leukaemia.
MLA
Geissler, K., et al. “Recombinant Human Megakaryocyte Growth and Development Factor Increases Levels of Circulating Haemopoietic Progenitor Cells Post Chemotherapy in Patients with Acute Myeloid Leukaemia.” British Journal of Haematology, vol. 102, no. 2, July 1998, pp. 535–43. EBSCOhost, https://doi.org/10.1046/j.1365-2141.1998.00789.x.
APA
Geissler, K., Kabrna, E., Stengg, S., Schwarzinger, I., Knöbl, P., Valent, P., Eichinger, S., Barge, A., & Lechner, K. (1998). Recombinant human megakaryocyte growth and development factor increases levels of circulating haemopoietic progenitor cells post chemotherapy in patients with acute myeloid leukaemia. British Journal of Haematology, 102(2), 535–543. https://doi.org/10.1046/j.1365-2141.1998.00789.x
Chicago
Geissler, K, E Kabrna, S Stengg, I Schwarzinger, P Knöbl, P Valent, S Eichinger, A Barge, and K Lechner. 1998. “Recombinant Human Megakaryocyte Growth and Development Factor Increases Levels of Circulating Haemopoietic Progenitor Cells Post Chemotherapy in Patients with Acute Myeloid Leukaemia.” British Journal of Haematology 102 (2): 535–43. doi:10.1046/j.1365-2141.1998.00789.x.